These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8461338

  • 1. The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat.
    Mitchell A, Fidge N, Griffiths P.
    Biochim Biophys Acta; 1993 Mar 17; 1167(1):9-14. PubMed ID: 8461338
    [Abstract] [Full Text] [Related]

  • 2. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun 17; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 3. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat.
    Felgines C, Mazur A, Rayssiguier Y.
    Life Sci; 1994 Jun 17; 55(13):1053-60. PubMed ID: 8084210
    [Abstract] [Full Text] [Related]

  • 4. Effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO).
    Felgines C, Sérougne C, Mathé D, Mazur A, Lutton C.
    Life Sci; 1994 Jun 17; 54(5):361-7. PubMed ID: 8289597
    [Abstract] [Full Text] [Related]

  • 5. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W, Infante J, Wang SR, Infante R.
    Biochim Biophys Acta; 1992 Jul 09; 1127(1):57-66. PubMed ID: 1627634
    [Abstract] [Full Text] [Related]

  • 6. The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. off.
    Shand JH, West DW.
    Lipids; 1995 Oct 09; 30(10):917-26. PubMed ID: 8538379
    [Abstract] [Full Text] [Related]

  • 7. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM, Carrilho AJ, Oliveira HC, Nakandakare ER, Quintão EC.
    Clin Exp Pharmacol Physiol; 2006 Dec 09; 33(12):1209-15. PubMed ID: 17184503
    [Abstract] [Full Text] [Related]

  • 8. Effect of simvastatin on the synthesis and secretion of lipoproteins in relation to the metabolism of cholesterol in cultured hepatocytes.
    Ribeiro A, Mangeney M, Loriette C, Thomas G, Pepin D, Janvier B, Chambaz J, Bereziat G.
    Biochim Biophys Acta; 1991 Nov 27; 1086(3):279-86. PubMed ID: 1742319
    [Abstract] [Full Text] [Related]

  • 9. The effect of cholestyramine on apolipoproteins in cholesterol-fed rabbits.
    Lacombe C, Corraze G, Nibbelink M.
    Artery; 1986 Nov 27; 13(4):203-12. PubMed ID: 3707359
    [Abstract] [Full Text] [Related]

  • 10. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Nov 27; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 11. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
    Huff MW, Telford DE.
    Metabolism; 1989 Mar 27; 38(3):256-64. PubMed ID: 2918845
    [Abstract] [Full Text] [Related]

  • 12. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
    Rabelink AJ, Hené RJ, Erkelens DW, Joles JA, Koomans HA.
    Lancet; 1988 Dec 10; 2(8624):1335-8. PubMed ID: 2904053
    [Abstract] [Full Text] [Related]

  • 13. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.
    Bard JM, Luc G, Douste-Blazy P, Drouin P, Ziegler O, Jacotot B, Dachet C, De Gennes JL, Fruchart JC.
    Eur J Clin Pharmacol; 1989 Dec 10; 37(6):545-50. PubMed ID: 2693115
    [Abstract] [Full Text] [Related]

  • 14. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H, Fujiya S, Aanuma Y, Agishi Y.
    Clin Ther; 1990 Dec 10; 12(5):410-20. PubMed ID: 2268863
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW, Baggen MG, Van Doormaal JJ, Kettner M, Koningsberger JC, Mol MJ.
    Drugs; 1988 Dec 10; 36 Suppl 3():87-92. PubMed ID: 3254824
    [Abstract] [Full Text] [Related]

  • 16. In vivo regulation of hepatic lipase activity and mRNA levels by diets which modify cholesterol influx to the liver.
    Benhizia F, Lagrange D, Malewiak MI, Griglio S.
    Biochim Biophys Acta; 1994 Mar 03; 1211(2):181-8. PubMed ID: 8117745
    [Abstract] [Full Text] [Related]

  • 17. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo.
    Bertolotti M, Abate N, Loria P, Dilengite M, Carubbi F, Pinetti A, Digrisolo A, Carulli N.
    Hepatology; 1991 Nov 03; 14(5):830-7. PubMed ID: 1937389
    [Abstract] [Full Text] [Related]

  • 18. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW, Van Erpecum KJ, Portincasa P, Renooij W, Erkelens DW, Van Berge-Henegouwen GP.
    Gut; 1995 Nov 03; 37(5):654-9. PubMed ID: 8549941
    [Abstract] [Full Text] [Related]

  • 19. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW.
    Cardiology; 1990 Nov 03; 77 Suppl 4():14-21. PubMed ID: 2073667
    [Abstract] [Full Text] [Related]

  • 20. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.